Research / GWAV / Fundamental state Inspectable configuration
State dimensions Filing 0001493152-23-010230 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
20.61% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
17.47% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-7.68% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
319.59% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
0.56% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
36.61% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-32.03% · CORE · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.00% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/4 normalized Amended as filed Dec 31, 2021 0/8 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/8 normalized Level 3 Dec 31, 2022 0/8 normalized Amended as filed Mar 31, 2023 2/7 normalized Level 3 Jun 30, 2023 2/7 normalized Level 3 Sep 30, 2023 2/6 normalized Level 3 Dec 31, 2023 2/8 normalized Level 3 Mar 31, 2024 6/7 normalized Level 3 Jun 30, 2024 6/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 6/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 6/6 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 15.20%
Current 17.47%
Delta 2.27% Cash Generation Increased
Previous -35.84%
Current -7.68%
Delta 28.16% Growth Decreased
Previous 13605868.52%
Current 319.59%
Delta -13605548.93% Inventory Pressure Decreased
Previous 9.77%
Current 0.56%
Delta -9.21% Margin Increased
Previous 33.82%
Current 36.61%
Delta 2.79% Profitability Increased
Previous -44.84%
Current -32.03%
Delta 12.81% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.